Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study

Title
Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study
Authors
Keywords
Methotrexate, Toxicity, Pharmacovigilance, Genetics, Polyglutamate
Journal
SEMINARS IN ARTHRITIS AND RHEUMATISM
Volume 47, Issue 1, Pages 133-142
Publisher
Elsevier BV
Online
2017-02-11
DOI
10.1016/j.semarthrit.2017.02.003

Ask authors/readers for more resources

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started